Emcure Pharmaceuticals has received market regulator SEBI’s nod for its IPO launch. The company had filed its DRHP on December 20, 2023. It aimed to be listed on both the stock exchanges, NSE and BSE. About the Issue: Emcure Pharmaceuticals receives a nod from SEBI to launch its IPO. The IPO consists of a fresh …


